← Evidence map

ReviewFrontiers in allergy2024

Omalizumab for the reduction of allergic reactions to foods: a narrative review.

Hafsa Ghouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38873398